RecruitMe Clinical Trial

Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial
Study to Find Out if Drug Will Prevent Severe Bleeding (Hemorrhage) after Cesarean Delivery (C-Section)
Sponsor:NICHD
Enrolling:Female Patients Only
Study Length:6 Weeks
IRB Number:AAAR6736
U.S. Government ID:NCT03364491
Contact: Sabine Bousleiman: 212-305-4348 / sb1080@cumc.columbia.edu
Additional Study Information:

When women have a cesarean delivery, there is an amount of bleeding. Occasionally (in less than 5 of every 100 births) there is severe bleeding that can place the mothers health at risk. When there is too much bleeding after a cesarean delivery, women are given medicines, blood transfusions, or possibly need another surgery. Tranexamic acid is routinely used to lessen the chance of hemorrhage. It works by making your blood clot sooner. It is not routinely used for cesarean sections. We are doing this study to see if this drug also works for women who are having a cesarean section. The study starts when you are having your cesarean section and continues until 6 weeks post-partum with follow-up phone calls. You will receive a telephone call one week after your delivery, and another call at 6 weeks after your delivery. The total compensation for participation in the study is $50.

Do You Qualify?
Will you have a cesarian delivery (c-section)?YesNo
Submit
Cancel
Investigator
Dr. Cynthia Gyamfi Bannerman
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Sabine Bousleiman
Email: sb1080@cumc.columbia.edu
Phone: 212-305-4348